Warning letter
Nobilus Ent: warning letter of Mar 7, 2012
FDA warning letter 273057 · Center for Drug Evaluation and Research
Key facts
| Reference number | 273057 |
|---|---|
| Company | Nobilus Ent |
| Subject | CGMP for Finished Pharmaceuticals/Adulterated |
| Issue date | Mar 7, 2012 |
| Posted date | Mar 7, 2012 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Inspection city | Kutno |
| Inspection start date | Sep 12, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: